12-862125-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_213655.5(WNK1):​c.1994C>T​(p.Thr665Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0659 in 1,613,962 control chromosomes in the GnomAD database, including 3,853 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T665A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.056 ( 307 hom., cov: 32)
Exomes 𝑓: 0.067 ( 3546 hom. )

Consequence

WNK1
NM_213655.5 missense

Scores

2
9
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 7.03

Publications

39 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026575327).
BP6
Variant 12-862125-C-T is Benign according to our data. Variant chr12-862125-C-T is described in ClinVar as Benign. ClinVar VariationId is 137924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.078 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.1994C>T p.Thr665Ile missense_variant Exon 8 of 28 ENST00000340908.9 NP_998820.3
WNK1NM_018979.4 linkc.1994C>T p.Thr665Ile missense_variant Exon 8 of 28 ENST00000315939.11 NP_061852.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.1994C>T p.Thr665Ile missense_variant Exon 8 of 28 5 NM_213655.5 ENSP00000341292.5
WNK1ENST00000315939.11 linkc.1994C>T p.Thr665Ile missense_variant Exon 8 of 28 1 NM_018979.4 ENSP00000313059.6

Frequencies

GnomAD3 genomes
AF:
0.0557
AC:
8471
AN:
152050
Hom.:
308
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0132
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0668
Gnomad ASJ
AF:
0.0861
Gnomad EAS
AF:
0.0845
Gnomad SAS
AF:
0.0301
Gnomad FIN
AF:
0.0811
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0732
Gnomad OTH
AF:
0.0636
GnomAD2 exomes
AF:
0.0661
AC:
16604
AN:
251344
AF XY:
0.0656
show subpopulations
Gnomad AFR exome
AF:
0.0121
Gnomad AMR exome
AF:
0.0741
Gnomad ASJ exome
AF:
0.0826
Gnomad EAS exome
AF:
0.0928
Gnomad FIN exome
AF:
0.0865
Gnomad NFE exome
AF:
0.0717
Gnomad OTH exome
AF:
0.0820
GnomAD4 exome
AF:
0.0670
AC:
97886
AN:
1461794
Hom.:
3546
Cov.:
32
AF XY:
0.0665
AC XY:
48390
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0110
AC:
369
AN:
33476
American (AMR)
AF:
0.0750
AC:
3355
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0848
AC:
2216
AN:
26134
East Asian (EAS)
AF:
0.0797
AC:
3164
AN:
39698
South Asian (SAS)
AF:
0.0272
AC:
2344
AN:
86258
European-Finnish (FIN)
AF:
0.0828
AC:
4425
AN:
53410
Middle Eastern (MID)
AF:
0.106
AC:
609
AN:
5766
European-Non Finnish (NFE)
AF:
0.0696
AC:
77383
AN:
1111938
Other (OTH)
AF:
0.0666
AC:
4021
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
5392
10784
16176
21568
26960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2842
5684
8526
11368
14210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0556
AC:
8463
AN:
152168
Hom.:
307
Cov.:
32
AF XY:
0.0552
AC XY:
4107
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0132
AC:
548
AN:
41522
American (AMR)
AF:
0.0668
AC:
1020
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0861
AC:
299
AN:
3472
East Asian (EAS)
AF:
0.0845
AC:
438
AN:
5182
South Asian (SAS)
AF:
0.0295
AC:
142
AN:
4812
European-Finnish (FIN)
AF:
0.0811
AC:
859
AN:
10588
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0732
AC:
4978
AN:
68000
Other (OTH)
AF:
0.0629
AC:
133
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
397
794
1190
1587
1984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0701
Hom.:
1809
Bravo
AF:
0.0547
TwinsUK
AF:
0.0742
AC:
275
ALSPAC
AF:
0.0708
AC:
273
ESP6500AA
AF:
0.0166
AC:
73
ESP6500EA
AF:
0.0753
AC:
648
ExAC
AF:
0.0639
AC:
7756
Asia WGS
AF:
0.0390
AC:
135
AN:
3478
EpiCase
AF:
0.0853
EpiControl
AF:
0.0812

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 24, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 02, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pseudohypoaldosteronism type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jun 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;.;D;.;.
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.97
D;D;D;D;D
MetaRNN
Benign
0.0027
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
.;M;M;M;M
PhyloP100
7.0
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-3.5
D;D;D;.;D
REVEL
Benign
0.21
Sift
Uncertain
0.0010
D;D;D;.;D
Sift4G
Uncertain
0.0050
D;.;T;D;D
Polyphen
0.34
B;.;B;.;.
Vest4
0.52
MPC
0.13
ClinPred
0.030
T
GERP RS
5.9
PromoterAI
-0.031
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.46
gMVP
0.16
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2286007; hg19: chr12-971291; COSMIC: COSV60041888; COSMIC: COSV60041888; API